Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma

NCT07463599 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Carcinoma (mCRC)
Colorectal Cancer (CRC)
Adenomatous Polyposis Coli (APC) Gene Mutation
Catenin Beta-1 (CTNNB1) Gene Mutation

Interventions

DRUG: Tegavivint

Sponsor

HonorHealth Research Institute

Collaborators

[object Object]